换一批
换一批Possible Causes of Failing to Meet Primary Endpoints: A Systematic Review of Randomized Controlled Phase 3 Clinical Trials in Patients With Non-Small Cell Lung Cancer.
第一作者：
Mitsugu,Ikeda
第一单位：
1 Department of Regulatory Science, Graduate School of Pharmaceutical Sciences, Nagoya City University, Nagoya, Japan.
作者：
主题词
癌, 非小细胞肺(Carcinoma, Non-Small-Cell Lung);临床试验, Ⅲ期(主题)(Clinical Trials, Phase III as Topic);无病生存(Disease-Free Survival);终点测定(Endpoint Determination);女(雌)性(Female);人类(Humans);肺肿瘤(Lung Neoplasms);男(雄)性(Male);随机对照试验(主题)(Randomized Controlled Trials as Topic);治疗结果(Treatment Outcome)
DOI
10.1177/2168479018791135
PMID
30089401
发布时间
2020-01-27
- 浏览5
Therapeutic innovation & regulatory science
2019年53卷3期
324-331页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文
